Michael Patrick Boyle, MD
Pulmonology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Michael Patrick Boyle
Primary Academic Title
Adjunct Professor of Medicine
Background
Dr. Michael Boyle is an Adjunct Professor of Medicine at the Johns Hopkins University School of Medicine, and President and CEO of the U.S. Cystic Fibrosis Foundation. His areas of expertise include adult cystic fibrosis care and research. Dr. Boyle founded and directed the Johns Hopkins Adult Cystic Fibrosis Program from 1999 to 2015 at the Johns Hopkins Cystic Fibrosis Center. Dr. Boyle completed all of his medical training at Johns Hopkins including fellowship in pulmonary and critical care medicine before joining the Johns Hopkins faculty in 1999. He is internationally known both for his clinical research in CFTR modulators and for his work to improve care for adults with cystic fibrosis. While at Johns Hopkins he has received numerous honors including the American Lung Association’s George Comstock Career Achievement Award, American Federation of Clinical Research Achievement Award, “Patient’s Choice Award”, “Best Full-Time Faculty Teacher”, and “Best Doctors in America”.
Centers and Institutes
Contact for Research Inquiries
1830 E. Monument Street, 5th floor
Division of Pulmonary and Critical Care Medicine
Baltimore, MD 21205
Research Interests
CFTR Modulators, Cystic Fibrosis Clinical Trials, Difficult to Treat Infections in Cystic Fibrosis
Research Summary
Dr. Boyle is internationally known for his clinical research in both CFTR modulators and difficult to treat lung infections. He has been the principal investigator for international clinical trials of CFTR modulator therapies which resulted in approval of new therapies for individuals with cystic fibrosis.
Selected Publications
Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR, Rodman D. on behalf of the VX09-809-102 Study Group. Randomised Trial of Combined CFTR Corrector and Potentiator Therapy in F508del-CFTR Cystic Fibrosis. The Lancet – Respiratory Medicine. 2: 527-38, 2014. PMID: 24973281
Boyle MP, Sabadosa KA, Quinton HB, Marshall BC, Schechter MS. Key Findings of the Cystic Fibrosis Foundation's U.S. Clinical Practice Benchmarking Project. BMJ Quality and Safety. 23:15-22, 2014. PMID: 24608546
Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association of Respiratory Tract Methicillin-Resistant Staphylococcus Aureus and Survival in Cystic Fibrosis. JAMA 303:2386-92, 2010. PMID: 20551409
Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent Methicillin-resistant Staphylococcus Aureus and Rate of FEV1 Decline in Cystic Fibrosis. Am J Respir Crit Care Med 178:814-821; 2008. PMID: 18669817
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 373:220-31, 2015. PMID: 25981758
Honors
- Best Doctors in America
- Alpha Omega Alpha (AOA), Johns Hopkins Chapter, 1/1/06
Professional Activities
- Cystic Fibrosis Foundation, Senior Vice President of Therapeutics Development, 4/15/15
- Cystic Fibrosis Foundation, President and CEO, 1/1/20
Locations
- Johns Hopkins Outpatient Center
- 601 North Caroline Street, Floor 7, Baltimore, MD 21287
- phone: 410-550-5864
- fax: 410-367-2014
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Pulmonary and Critical Care Medicine, 1999Johns Hopkins University School of Medicine
Residency, Internal Medicine, 1994Johns Hopkins University School of Medicine
Medical Education, MD, 1991Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)